Overview
2012 Accommodations Update:
Please contact Grant/Downing at 303-407-3411 x100 for assistance with accommodations at the Viceroy. An additional block of rooms has been secured at the Stonebridge Inn, located less than a mile from the Viceroy. Click here for complete information.
The 38th Remington
Winter Course in Infectious Diseases
February 12-17, 2012, Snowmass, Colorado
Course Description
Thirty-seven years ago, this course was developed in an effort to contribute high-quality medical and scientific information and to provide continuing medical education to physicians. This high level of education has continued and has now evolved into one of the premier infectious diseases courses in the United States. This year, we will pay special attention to the treatment of infection in the transplant recipient; emerging treatments and issues associated with orthopedic infections; various approaches to the treatment of fungal infections; management of HIV/AIDS, including HAART, opportunistic infections, and drug-drug interactions; emerging infections due to antibiotic resistant pathogens, including MRSA, VRE, and MDR GNR; best practices in the screening, diagnosis, prevention and treatment of C difficile infections; optimal treatment approaches to the care of patients with hepatitis C virus infection; and new information gained from broad topic updates in areas of interest to ID specialists and internal medicine physicians including vaccines, meningitis, travel related infections, septic shock, and emerging infections. Topics will be presented in lectures, panel discussions, debates, case presentations, and question and answer sessions. Meet the professor sessions will allow for personal exchange between participants and faculty.
Needs Assessment
The importance of infectious diseases in health and medical care has increasingly grown larger and more complex, and often involves older populations with co-morbidities and impaired host defenses, resulting in increasing morbidity and mortality. Peer-reviewed literature, a survey of the target audience, clinical guidelines, the evolution of new infections, occurrences of rare infections, advances in treatment options, and federal regulations regarding nonpayment of specific hospital-acquired infections provide a sufficient evidence basis to support the scientific need for this important educational event.
Target Audience
This course is designed for and will benefit physicians, microbiologists, pharmacists, nurse practitioners and physicians’ assistants who are involved with the diagnosis, management, and treatment of infectious diseases, including HIV/AIDS.
Course Objectives
Upon completion of this course, participants should be better able to:
- Summarize current best practices in the treatment of infection in the transplant patient with a focus on multi-drug resistant pathogens.
- Outline the various approaches to the treatment of patients at risk for opportunistic fungal infections or endemic mycoses.
- Examine the current guidelines for preventing and treating opportunistic infections in patients with HIV/AIDS, including the monitoring recommendations for patients receiving HAART.
- Identify treatment strategies and infection control practices for drug-resistant infections such as MRSA, VRE, Acinetobacter, and NDM-1 producing Enterobacteriaceae.
- Optimal infection control protocols to reduce exposure to C difficile and treatment strategies for resistant and relapsed infection.
- Discuss appropriate use of monotherapy and combination therapy for the individualized treatment of patients with hepatitis C virus infection.
- Evaluate the use of pharmacokinetic/pharmacodynamic principles in achieving effective therapy in an environment of emerging antibiotic resistance.
- Apply new information gained from broad topic updates in areas of interest to ID specialists and internal medicine physicians, including influenza, community and ventilator-acquired pneumonia, urinary tract infections, meningitis, and emerging infections
Course Directors
| A.W. Karchmer, MD
Professor of Medicine |
Richard P. Wenzel, MD, MSc
William Branch Porter Professor and Former Chair |
|
 |
||
|
Course Founder and Honorary Course Director
Jack S. Remington, MD, FACP, FRCP
|
||
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The University of Nebraska Medical Center, Center for Continuing Education and Winter Course in Infectious Diseases.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 28.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Early Bird Registration – until 9/30/11 – $595
Discounted Registration – until 12/9//11 – $695- Regular Registration – after 12/9/11 – $795
- Fellows, Residents, Students & Allied Health Professionals – $250
Criteria for Postdoctoral Fellows and Residents
To be eligible for the reduced fee, you must be employed by an institution as a postdoctoral fellow who is within two years of graduation or a medical resident who is within six years of receipt of the M.D. degree. Proof of status is by letter from the head of the program on official university letterhead.
Criteria for Student Rate
Any undergraduate or pre-doctoral student requesting the student rate must provide either a legible photocopy of a current University ID or a letter on university letterhead from the department chair, indicating your status and anticipated graduation date.
Cancellation Policy
If your registration must be canceled and your request is received in writing on or before January 6, 2012, your paid tuition, less a $75 administrative fee, will be refunded. No refunds will be granted after January 6, 2012.
